Baxter International Inc. (BAX) Stock Forecast
Data as of Aug 1, 2026Healthcare · Current price $26.28 (-1.76%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 16, 2026 | Danielle Antalffy | UBS | $19.00 | -27.7% |
| Jan 9, 2026 | Matt Miksic | Barclays | $30.00 | +14.2% |
| Jan 5, 2026 | Vijay Kumar | Evercore ISI | $23.00 | -12.5% |
| Dec 2, 2025 | Patrick Wood | Morgan Stanley | $15.00 | -42.9% |
| Oct 31, 2025 | David Roman | Goldman Sachs | $22.00 | -16.3% |
| Jan 2, 2025 | Vijay Kumar | Evercore ISI | $42.00 | +59.8% |
| Oct 4, 2024 | Travis Steed | Bank of America Securities | $45.00 | +71.2% |
| Aug 6, 2024 | Matthew Taylor | Jefferies | $42.00 | +59.8% |
| Jul 15, 2024 | Patrick Wood | Morgan Stanley | $30.00 | +14.2% |
| Jun 12, 2024 | David Roman | Goldman Sachs | $36.00 | +37.0% |
| May 3, 2024 | Danielle Antalffy | UBS | $40.00 | +52.2% |
| May 2, 2024 | Matthew Taylor | Jefferies | $43.00 | +63.6% |
| May 2, 2024 | Rick Wise | Stifel Nicolaus | $44.00 | +67.4% |
| Jul 31, 2023 | Matt Miksic | Barclays | $54.00 | +105.5% |
| Jul 31, 2023 | Philippe Houchois | Jefferies | $85.00 | +223.4% |
| Mar 27, 2023 | Joanne Wuensch | Citigroup | $44.00 | +67.4% |
| Mar 3, 2022 | Travis Steed | Bank of America Securities | $100.00 | +280.5% |
| Feb 18, 2022 | David Lewis | Morgan Stanley | $105.00 | +299.5% |
| Feb 13, 2022 | Amit Hazan | Goldman Sachs | $91.00 | +246.3% |
| Jan 7, 2022 | Joanne Wuensch | Citigroup | $101.00 | +284.3% |
Top Analysts Covering BAX
BAX vs Sector & Market
| Metric | BAX | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.87 | 2.25 | 2.42 |
| Analyst Count | 15 | 8 | 19 |
| Target Upside | -4.7% | +16366.1% | +18.0% |
| P/E Ratio | -9.64 | 3.02 | 43.33 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $11.33B | $11.36B | $11.40B | 11 |
| 2027-03-31 | $2.65B | $2.68B | $2.72B | 4 |
| 2027-06-30 | $2.80B | $2.84B | $2.88B | 6 |
| 2027-09-30 | $2.89B | $2.93B | $2.97B | 4 |
| 2027-12-31 | $3.06B | $3.10B | $3.14B | 7 |
| 2028-03-31 | $2.71B | $2.75B | $2.78B | 3 |
| 2028-06-30 | $2.93B | $2.96B | $3.00B | 5 |
| 2028-09-30 | $2.98B | $3.01B | $3.05B | 3 |
| 2028-12-31 | $3.10B | $3.14B | $3.18B | 6 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1.85 | $1.91 | $1.95 | 8 |
| 2027-03-31 | $0.39 | $0.40 | $0.41 | 3 |
| 2027-06-30 | $0.42 | $0.43 | $0.44 | 3 |
| 2027-09-30 | $0.52 | $0.53 | $0.54 | 4 |
| 2027-12-31 | $0.65 | $0.66 | $0.67 | 3 |
| 2028-03-31 | $0.64 | $0.65 | $0.67 | 4 |
| 2028-06-30 | $0.77 | $0.78 | $0.80 | 4 |
| 2028-09-30 | $0.75 | $0.76 | $0.78 | 6 |
| 2028-12-31 | $0.81 | $0.82 | $0.84 | 4 |
Frequently Asked Questions
What is the analyst consensus for BAX?
The consensus among 15 analysts covering Baxter International Inc. (BAX) is Hold with an average price target of $20.33.
What is the highest price target for BAX?
The highest price target for BAX is $105.00, set by David Lewis at Morgan Stanley on 2022-02-18.
What is the lowest price target for BAX?
The lowest price target for BAX is $15.00, set by Patrick Wood at Morgan Stanley on 2025-12-02.
How many analysts cover BAX?
15 analysts have issued ratings for Baxter International Inc. in the past 12 months.
Is BAX a buy or sell right now?
Based on 15 analyst ratings, BAX has a consensus rating of Hold (2.87/5) with a -4.7% upside to the consensus target of $20.33.
What are the earnings estimates for BAX?
Analysts estimate BAX will report EPS of $1.91 for the period ending 2026-12-31, with revenue estimated at $11.36B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.